CVE:BED

Bedrocan Cannabis Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.

Add

Today's Range: N/A
50-Day Range: N/A
52-Week Range: N/A

Volume: N/A
Average Volume: 171,120 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Beta: N/A

Receive BED News and Ratings via Email

Sign-up to receive the latest news and ratings for Bedrocan Cannabis and its competitors with MarketBeat's FREE daily newsletter.

About Bedrocan Cannabis

Bedrocan Cannabis Corp., formerly POCML 2 Inc., is engaged in the import and sale of medicinal cannabis in Canada.

Greenrise Global's Supports Germany's Approach to Cannabis Legalization for Adult Use
November 25, 2021 | finance.yahoo.com

Greenrise Global's Medical Cannabis Subsidiary Announces the Introduction of its Dronabinol Product to the German Market
November 17, 2021 | ca.finance.yahoo.com

Stop Using Indica And Sativa Labels For Cannabis, Study Says
October 20, 2021 | forbes.com

Xebra Brands Completes Construction of Cannabis Facility in the Netherlands
October 19, 2021 | finance.yahoo.com

Gage Growth to be acquired by TerrAscend in US$545M deal to create new US multistate operator
September 1, 2021 | proactiveinvestors.com

Gage Growth: The steady hand wins the race in this cannabis company’s playbook
August 31, 2021 | proactiveinvestors.com

‘We did it!’ Vera Twomey wins medicinal cannabis fight for daughter Ava
July 20, 2021 | msn.com

Epilepsy kids hit by cannabis red tape as Scots MP calls for quicker action
June 27, 2021 | msn.com

Upfront State payment for medical cannabis on cards as minister asks officials to explore options
June 12, 2021 | msn.com

RYAH Medtech Inc. Ships Devices for Use in Pilot Study with CLINN Medical Center
May 25, 2021 | markets.businessinsider.com

Family of Scots boy fear seizures will return as Brexit blocks vital cannabis oil supplies from Holland
May 25, 2021 | msn.com

‘€9.5k burden is too much to bear’ — Family wants cost of epileptic daughter’s medicine paid at source
April 13, 2021 | msn.com

Non-opioid Pain Treatment Market 2020 Business Strategies, Production and Comprehensive Research Study till 2025
March 13, 2021 | marketwatch.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange: CVE
Industry: N/A
Sub-Industry: Cannabis
Sector: N/A
Current Symbol: CVE:BED
Previous Symbol
CUSIP: N/A
CIK: N/A
Web: N/A
Phone: +1-416-9435800
Fax: N/A
Employees: N/A
Year Founded: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Price-To-Earnings

Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable

MarketRank^™

Overall MarketRank^™

0.85 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Bedrocan Cannabis.

4.3 Community Rank

Outperform Votes
Bedrocan Cannabis has received 64 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Bedrocan Cannabis has received 36 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Bedrocan Cannabis has received 64.00% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Bedrocan Cannabis and other stocks. Vote “Outperform” if you believe BED will outperform the S&P 500 over the long term. Vote “Underperform” if you believe BED will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Bedrocan Cannabis does not currently pay a dividend.
Dividend Growth
Bedrocan Cannabis does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Bedrocan Cannabis insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

Bedrocan Cannabis (CVE:BED) Frequently Asked Questions

Who are some of Bedrocan Cannabis' key competitors?: Some companies that are related to Bedrocan Cannabis include Innovative Industrial Properties (IIPR), Canopy Growth (WEED), Cronos Group (MJN), GrowGeneration (GRWG), OrganiGram (OGI), CanniMed Therapeutics (CMED), 22nd Century Group (XXII), Emblem (EMC), Leaf Mobile (LEAF), ICC Labs (ICC), Net Savings Link (NSAV), Bioventix (BVXP), Maple Leaf Green World (MGW), KushCo (KSHB) and Unrivaled Brands (TRTC).
View all of BED's competitors.
What other stocks do shareholders of Bedrocan Cannabis own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Bedrocan Cannabis investors own include Leaf Mobile (LEAF), Surna (SRNA), Canopy Growth (WEED), CannTrust (CTST), (CGC), 27221 (LGO.V) (LGO), SRG Mining (SRG), Aurora Cannabis (ACBFF), Singing Machine (SMDM) and Trulieve Cannabis (TCNNF).
What is Bedrocan Cannabis' stock symbol?: Bedrocan Cannabis trades on the Canadian Venture Exchange (CVE) under the ticker symbol "BED."
Where are Bedrocan Cannabis' headquarters?: Bedrocan Cannabis is headquartered at 77 King Street West Suite 400, Toronto-Dominion Centre, TORONTO, ON M5K 0A1, Canada.
How can I contact Bedrocan Cannabis?: Bedrocan Cannabis' mailing address is 77 King Street West Suite 400, Toronto-Dominion Centre, TORONTO, ON M5K 0A1, Canada. The company can be reached via phone at +1-416-9435800.

This page was last updated on 12/1/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms

Your Ultimate Investing Toolkit

Just $1.00 for your first month.